Tradestie Institutional Equity Comparison Engine
CING vs INSM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
INSM Overall Edge
INSM Captures Institutional Edge (3โ1 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Insmed, Inc. (INSM) driven by superior Valuation, Momentum & Technical, Options & Structure while CING counters with relative strength in Growth & Margin. Fundamentally, CING trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus INSM at N/M Forward P/E and -41.7% operating margin (+268.4% YoY). In options structure, CING sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro) against INSM sits in CONSOLIDATION (38th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
INSM
CING N/M vs INSM N/M Fwd P/E
Growth & Margin Winner
CING
Op Margin 0.0% vs -41.7% ยท YoY +0.0% vs +268.4%
Momentum & Technical Winner
INSM
1Y +36.4% vs -37.1% ยท 52W Pos 18% vs 25%
Options & Structure Winner
INSM
BREAKDOWN (16th %ile IV) vs CONSOLIDATION (38th %ile IV)
CING
NASDAQ
Cingulate Inc. Common Stock
Pharmaceutical Preparations
$4.76
+26.93% 1D
Market Cap
$62.5M
1M Return
+9.17%
1Y Return
+36.39%
Forward P/E
N/M
Unified AI Score
44.8 / 100
HOLD
Tech 31.0
Fund 50.0
Flow 67.0
Mom 60.0
INSM
NASDAQ
Insmed, Inc.
Pharmaceutical Preparations
$121.44
-1.18% 1D
Market Cap
$26.6B
1M Return
+27.44%
1Y Return
-37.15%
Forward P/E
N/M
Unified AI Score
34.3 / 100
SELL
Tech 50.0
Fund 33.0
Flow 68.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CING +36.39%
INSM -37.15%
Spread: +73.54 pp (CING Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CING TTM Op. Margin: 0.0%
INSM TTM Op. Margin: -41.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CING vs INSM. Trailing 12-month operating profitability (CING 0.0% vs INSM -41.7%) and valuation multiples (CING N/M vs INSM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CING | INSM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.5M | $26.6B | Larger Scale | INSM |
| Trailing P/E Ratio Valuation | N/M | 107.5x | Lower Multiple | INSM |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +268.4% | Higher Growth | INSM |
| Operating Margin (TTM) Profitability | 0.0% | -41.7% | Higher Margin | CING |
| Net Profit Margin Profitability | 0.0% | -39.9% | Higher Margin | CING |
| Return on Equity (ROE) Capital Efficiency | -198.7% | -72.5% | Higher ROE | INSM |
| 52-Week Range Position Momentum | 18% ($3โ$12) | 25% ($90โ$213) | Stronger Trend | INSM |
| Beta / 30D Volatility Risk Regime | 1.13ฮฒ ยท 117% Vol | 0.65ฮฒ ยท 62% Vol | Lower Realized Risk | INSM |
| Unified Institutional Score Composite Signal | 44.8 / 100 (HOLD) | 34.3 / 100 (SELL) | Higher Composite | CING |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CING vs INSM Buy Guide
CING
BREAKDOWN
170d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
16th %ile
IV Regime
Compressed (<25th %ile)
INSM
CONSOLIDATION
70d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
38th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CING nor INSM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.